-
-
Call more information
660-596-2224 -
We would like to thank all of the heroes that make today possible for those of us who live in the greatest nation in the world. All of our readers please enjoy your family and be safe.
Read MoreThe U.S. Food and Drug Administration has approved erenumab (Aimovig™, Amgen and Novartis), a first-in-class calcitonin gene-related peptide (CGRP) antagonist, for the prevention of migraine in adults. Erenumab consistently demonstrated an ability to reduce monthly migraine days in patients with episodic and chronic migraine in 3 major clinical trials, ARISE, STRIVE, and LIBERTY. The drug, which is […]
Read Moreauthors: Evan M. Bloch, M.B., Ch.B., et al N Engl J Med May 2018; 378:1837-1841 The rapid, pandemic spread of Zika virus (ZIKV) spurred an international public health emergency in 2015. Cases of ZIKV infection have now been reported in 85 countries or territories1; in 72 of those locations, no such cases had been […]
Read MoreHarvard Business Review Dec 15, 2017 Authors: Jennifer Perry et al Rising pressure to achieve better medical outcomes with increasingly limited financial resources has created an acute need for more physician leaders. Several studies (including this one) have shown that doctors want to be led by other doctors; they trust physician leaders to make the right […]
Read MoreAUTHORS: Anoop Ramgolam, Ph.D. et al Anesthesiology 6 2018, Vol.128, 1065-1074. Background: Limited evidence suggests that children have a lower incidence of perioperative respiratory adverse events when intravenous propofol is used compared with inhalational sevoflurane for the anesthesia induction. Limiting these events can improve recovery time as well as decreasing surgery waitlists and healthcare costs. This single […]
Read More